Fig. 3.
Impact of RXB pretreatments (75 and 150 mg/kg) for Con A-challenged mice on the hepatic immunohistochemical expression and quantification of NF-κB (A and B; 100×; scale bar = 100 μm) and hepatic and serum concentrations of IL-1β (C and D) (n = 6–8/group). ** and *** denote a P-value (vs. the Control) less than 0.01 and 0.001, respectively, but #, ## and ### denote a P-value (vs. the Con A) less than 0.05, 0.01 and 0.001, respectively.